Hemera Biosciences


Hemera Biosciences develops anti-complement gene-based therapies for the treatment of dry and wet age-related macular degeneration.

Employees

1-10

Links


Org chart

Adam Rogers
Chief Executive Officer and Founder
Collapse
No reports!

Teams

This company has no teams yet


Offices